ACE2 News and Research

RSS
CRISPR screening identifies human host pathways that facilitate coronavirus infection

CRISPR screening identifies human host pathways that facilitate coronavirus infection

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

Linoleic acid binds SARS-CoV-2 spike protein

Linoleic acid binds SARS-CoV-2 spike protein

Genetic variation not linked with differences in COVID-19 morbidity and mortality

Genetic variation not linked with differences in COVID-19 morbidity and mortality

AI used to define the cytokine storm implicated in fatal COVID-19

AI used to define the cytokine storm implicated in fatal COVID-19

Researchers uncover an active role of glycans in SARS-CoV-2 spike protein

Researchers uncover an active role of glycans in SARS-CoV-2 spike protein

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

Bat and pangolin coronavirus structure sheds light on SARS-CoV-2 evolution

Bat and pangolin coronavirus structure sheds light on SARS-CoV-2 evolution

Bioinformatics analysis reveals genes and pathways shared in COVID-19 disease and comorbidities

Bioinformatics analysis reveals genes and pathways shared in COVID-19 disease and comorbidities

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

Molecular dynamic simulations reveal detailed spike-ACE2 interactions

Molecular dynamic simulations reveal detailed spike-ACE2 interactions

Common genetic variants may influence susceptibility to COVID-19

Common genetic variants may influence susceptibility to COVID-19

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2